Lumexa Imaging (LMRI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $10.78, +2.08% vs the prior close of $10.56.
- Volume 371.30K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LMRI rises 2.1% to $10.78. Closed at $10.78, +2.08% vs the prior close of $10.56. Day range $10.60–$10.99, opened at $10.73.
LMRI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LMRI rises 2.1% to $10.78
- Closed at $10.78, +2.08% vs the prior close of $10.56. Day range $10.60–$10.99, opened at $10.73.
- Volume was 371.30K shares, 0.9x its 50-day average of 430.00K.
- Price is -4.0% vs its 50-day average ($11.23) and -5.6% vs its 200-day average ($11.42).
- 52-week range $6.45–$19.45; today's close sits at 33% of that range, 44.6% below the 52-week high.
Oct 14, 2026 — LMRI dips 0.5% to $10.56
- Closed at $10.56, -0.47% vs the prior close of $10.61. Day range $10.35–$10.67, opened at $10.43.
- Volume was 201.80K shares, 0.5x its 50-day average of 439.18K — lighter than usual.
- Price is -6.0% vs its 50-day average ($11.24) and -7.8% vs its 200-day average ($11.46).
- 52-week range $6.45–$19.45; today's close sits at 32% of that range, 45.7% below the 52-week high.
Oct 13, 2026 — LMRI dips 0.7% to $10.61
- Closed at $10.61, -0.66% vs the prior close of $10.68. Day range $10.40–$10.98, opened at $10.76.
- Volume was 297.60K shares, 0.7x its 50-day average of 441.72K.
- Price is -5.7% vs its 50-day average ($11.25) and -7.7% vs its 200-day average ($11.49).
- 52-week range $6.45–$19.45; today's close sits at 32% of that range, 45.4% below the 52-week high.
Oct 12, 2026 — LMRI rises 1.3% to $10.68
- Closed at $10.68, +1.33% vs the prior close of $10.54. Day range $10.19–$10.73, opened at $10.56.
- Volume was 185.40K shares, 0.4x its 50-day average of 444.81K — lighter than usual.
- Price is -5.2% vs its 50-day average ($11.27) and -7.4% vs its 200-day average ($11.53).
- 52-week range $6.45–$19.45; today's close sits at 33% of that range, 45.1% below the 52-week high.
Oct 9, 2026 — LMRI rises 2.0% to $10.54
- Closed at $10.54, +2.03% vs the prior close of $10.33. Day range $10.12–$10.66, opened at $10.34.
- Volume was 370.90K shares, 0.8x its 50-day average of 445.09K.
- Price is -6.4% vs its 50-day average ($11.26) and -8.9% vs its 200-day average ($11.57).
- 52-week range $6.45–$19.45; today's close sits at 31% of that range, 45.8% below the 52-week high.
Oct 8, 2026 — LMRI dips 2.5% to $10.33, 3 down days in a row
- Closed at $10.33, -2.46% vs the prior close of $10.59. Day range $10.10–$10.50, opened at $10.45.
- Volume was 492.10K shares, 1.1x its 50-day average of 443.25K.
- Price is -8.2% vs its 50-day average ($11.26) and -11.0% vs its 200-day average ($11.61).
- 52-week range $6.45–$19.45; today's close sits at 30% of that range, 46.9% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — LMRI dips 1.1% to $10.59
- Closed at $10.59, -1.12% vs the prior close of $10.71. Day range $10.49–$10.71, opened at $10.57.
- Volume was 164.00K shares, 0.4x its 50-day average of 447.19K — lighter than usual.
- Price is -5.9% vs its 50-day average ($11.25) and -9.0% vs its 200-day average ($11.64).
- 52-week range $6.45–$19.45; today's close sits at 32% of that range, 45.6% below the 52-week high.
Oct 6, 2026 — LMRI dips 0.6% to $10.71
- Closed at $10.71, -0.56% vs the prior close of $10.77. Day range $10.55–$11.08, opened at $10.93.
- Volume was 258.10K shares, 0.6x its 50-day average of 446.77K — lighter than usual.
- Price is -4.9% vs its 50-day average ($11.26) and -8.3% vs its 200-day average ($11.68).
- 52-week range $6.45–$19.45; today's close sits at 33% of that range, 44.9% below the 52-week high.
Oct 5, 2026 — LMRI jumps 4.4% to $10.77
- Closed at $10.77, +4.36% vs the prior close of $10.32. Day range $10.50–$10.93, opened at $10.61.
- Volume was 616.20K shares, 1.4x its 50-day average of 439.29K.
- Price is -4.4% vs its 50-day average ($11.27) and -8.0% vs its 200-day average ($11.71).
- 52-week range $6.45–$19.45; today's close sits at 33% of that range, 44.6% below the 52-week high.
Oct 2, 2026 — LMRI rises 2.2% to $10.32
- Closed at $10.32, +2.18% vs the prior close of $10.10. Day range $10.18–$10.50, opened at $10.30.
- Volume was 476.40K shares, 1.1x its 50-day average of 435.68K.
- Price is -8.4% vs its 50-day average ($11.27) and -12.1% vs its 200-day average ($11.74).
- 52-week range $6.45–$19.45; today's close sits at 30% of that range, 46.9% below the 52-week high.
LMRI latest news & SEC filings
Every SEC filing by or about LMRI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $264.16M (prior year $251.40M) (+5.1% vs Jun 30, 2025)
- Net income: $2.75M (prior year -$7.23M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.03 (prior year -$0.10) (swung to profit vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Things to know before you trade LMRI
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 26, 2026, Mar 2, 2026. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.95% (largest 4.4%).
- Liquidity: about 434.01K shares (≈$4.68M) trade per day on average.
- 52-week position: $10.78 vs a range of $6.45–$19.45 (33% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 2 open-market buys, 0 sales; latest: Brett Brodnax bought 35,000 shares on May 19, 2026.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 12, 2026; 8-K Jun 30, 2026.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
LMRI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 10.73 | 10.99 | 10.60 | 10.78 | 371.30K |
| Oct 14, 2026 | 10.43 | 10.67 | 10.35 | 10.56 | 201.80K |
| Oct 13, 2026 | 10.76 | 10.98 | 10.40 | 10.61 | 297.60K |
| Oct 12, 2026 | 10.56 | 10.73 | 10.19 | 10.68 | 185.40K |
| Oct 9, 2026 | 10.34 | 10.66 | 10.12 | 10.54 | 370.90K |
| Oct 8, 2026 | 10.45 | 10.50 | 10.10 | 10.33 | 492.10K |
| Oct 7, 2026 | 10.57 | 10.71 | 10.49 | 10.59 | 164.00K |
| Oct 6, 2026 | 10.93 | 11.08 | 10.55 | 10.71 | 258.10K |
| Oct 5, 2026 | 10.61 | 10.93 | 10.50 | 10.77 | 616.20K |
| Oct 2, 2026 | 10.30 | 10.50 | 10.18 | 10.32 | 476.40K |
| Oct 1, 2026 | 10.28 | 10.52 | 9.94 | 10.10 | 379.50K |
| Sep 30, 2026 | 10.26 | 10.48 | 9.93 | 10.25 | 781.60K |
| Sep 29, 2026 | 10.20 | 10.31 | 10.07 | 10.26 | 379.60K |
| Sep 28, 2026 | 10.10 | 10.31 | 9.98 | 10.15 | 165.30K |
| Sep 25, 2026 | 10.25 | 10.27 | 9.86 | 10.21 | 441.20K |
| Sep 24, 2026 | 10.11 | 10.16 | 9.83 | 9.88 | 326.20K |
| Sep 23, 2026 | 10.44 | 10.58 | 10.00 | 10.14 | 981.00K |
| Sep 22, 2026 | 10.80 | 11.07 | 10.49 | 10.52 | 658.70K |
| Sep 21, 2026 | 11.17 | 11.46 | 10.58 | 10.68 | 455.20K |
| Sep 18, 2026 | 11.44 | 11.45 | 11.00 | 11.08 | 678.20K |
About Lumexa Imaging
Lumexa Imaging (LMRI) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in RALEIGH, NC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2071288.
LMRI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Brett Brodnax | Director | Jun 12, 2026 |
| Henry Lee Cooper | Director | Jun 12, 2026 |
| Glenn A Eisenberg | Director | Jun 12, 2026 |
| Molly Joseph | Director | Jun 12, 2026 |
| Bridget E Karlin | Director | Jun 12, 2026 |
| Matthew Lungren | Director | Jun 12, 2026 |
| Robert Louis Jr. Mittl | Director | Jun 12, 2026 |
| Brian Thomas Regan | Director | Dec 11, 2025 |
| Caitlin Zulla | Chief Executive Officer | Dec 16, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| James Anthony Martin | Chief Financial Officer | Jan 15, 2026 |
| Russell Stewart | Chief Medical Officer | Dec 16, 2025 |
| Julie Szeker | Chief Legal Officer & Corp Sec | Dec 16, 2025 |
| James Edward Jr. Walker | Principal Accounting Officer | Feb 27, 2026 |
| Caitlin Zulla | Chief Executive Officer | Dec 16, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 19, 2026 | Brett Brodnax | Buy | 35,000 | $7.25 |
| May 14, 2026 | Henry Lee Cooper | Buy | 30,000 | $7.44 |
LMRI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $1.81B, total liabilities $1.19B, cash $69.70M (as of Jun 30, 2026).
LMRI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $11.73 |
| May 12, 2026 | 8-K Item 2.02 (results) | $10.50 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $7.76 |
| Mar 2, 2026 | 8-K Item 2.02 (results) | $15.87 |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Quest Diagnostics (DGX)Guardant Health (GH)Labcorp (LH)Celcuity (CELC)Caris Life Sciences (CAI)Grail (GRAL)CareDx (CDNA)Fortrea (FTRE)Veracyte (VCYT)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LMRI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.